During the past decade, Michael Gold, MD conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michael Gold, MD" #1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Michael Gold, MD" are "Athlete's Foot" (1 trials), "Atopic Dermatitis" (1 trials), "Dermatological Non-Disease" (1 trials), "Moderate or Severe Submental Fullness" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Michael Gold, MD" in a lesser frequency.

Most popular intervention types in "Michael Gold, MD" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deoxycholic acid injection" (1 trials), "Econazole Nitrate Cream 1%" (1 trials), "Econazole Nitrate Foam 1%" (1 trials), "Pandel Cream 0.1%" (1 trials) and "Princess Filler Lidocaine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michael Gold, MD" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Michael Gold, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Michael Gold, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michael Gold, MD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".